ClassID:

21000

A61K38/27 - page 3 - CPC Classification

Classification description:

Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans; Hormones Growth hormone [GH] (Somatotropin)

Recent Application in this class:
#601
20080118463
2008-05-22

Light Pharmaceutical Water and Therapeutic Compositions and Methods Thereof

#602
20080114155
2008-05-15

Modified Human Interferon Polypeptides and Their Uses

#603
20080114154
2008-05-15

Modified Human Interferon Polypeptides and Their Uses

#604
20080113914
2008-05-15

Modified human growth hormone formulations with an increased serum half-life

#605
20080113913
2008-05-15

Formulations of Human Growth Hormone Comprising a Non-Naturally Encoded Amino Acid

#606
20080113912
2008-05-15

Formulations of human growth hormone comprising a non-naturally encoded amino acid

#607
20080108797
2008-05-08

Modified Human Growth Hormone Polypeptides and Their Uses

#608
20080108791
2008-05-08

Modified human interferon polypeptides with at least one non-naturally encoded amino acid and their uses

#609
20080108554
2008-05-08

Method and apparatus for producing dry particles

#610
20080107680
2008-05-08

Modified Human Growth Hormone

#611
20080103294
2008-05-01

Modified Human Growth Hormone Polypeptides and Their Uses

#612
20080103293
2008-05-01

Modified Human Growth Hormone Polypeptides and Their Uses

#613
20080102128
2008-05-01

Modified-release microparticles based on amphiphilic copolymer and on active principles(s) and pharmaceutical formulations comprising them

#614
20080102125
2008-05-01

Modified human growth hormone

#615
20080102124
2008-05-01

Modified Human Growth Hormone

#616
20080102114
2008-05-01

Microparticles and Nanoparticles for the Transmucosal Delivery of Therapeutic and Diagnostic Agents

#617
20080097083
2008-04-24

Modified human four helical bundle polypeptides and their uses

#618
20080095837
2008-04-24

HUMAN GROWTH HORMONE FORMULATIONS

#619
20080090754
2008-04-17

Sustained release formulation

#620
20080085263
2008-04-10

Liquid depot formulations

#621
20080081787
2008-04-03

Medical compositions containing ghrelin

#622
20080038369
2008-02-14

Methods And Compositions For The Treatment Of Prolactin-Receptor Related Disorders

#623
20080038292
2008-02-14

Liquid growth hormone formulation and method of use

#624
20080026070
2008-01-31

Pharmaceutical formulations for the prolonged release of active principle(s), and their applications, especially therapeutic applications

#625
20080004217
2008-01-03

TREATMENT OF HIV-ASSOCIATED DYSMORPHIA/DYSMETABOLIC SYNDROME (HADDS) WITH OR WITHOUT LIPODYSTROPHY

#626
20070299006
2007-12-27

Recombinant fusion proteins to growth hormone and serum albumin

#627
20070298010
2007-12-27

Stabilizing alkylglycoside compositions and methods thereof

#628
20070287949
2007-12-13

Transdermal System for Sustained Delivery of Polypeptides

#629
20070282096
2007-12-06

Sialic acid derivatives

#630
20070275069
2007-11-29

Hydrophobic biomolecular structure

#631
20070275055
2007-11-29

Compositions capable of facilitating penetration across a biological barrier

#632
20070270489
2007-11-22

Remedy for Cartilage-Related Diseases

#633
20070265190
2007-11-15

Opioid depot formulations

#634
20070259047
2007-11-08

Protein Sustained-Release Microparticle Preparation for Injection and Process for Producing the Same

#635
20070243192
2007-10-18

Growth hormone receptor antagonist cancer treatment

#636
20070238662
2007-10-11

Use of ghrelin splice variant for treating cachexia and/or anorexia and/or anorexia-cachexia and/or malnutrition and/or lipodystrophy and/or muscle wasting and/or appetite-stimulation

#637
20070224182
2007-09-27

Therapeutic and prophylactic uses of cell specific carbonic anhydrase enzymes in treating aging disorders due to oxidative stress and as growth factors of stem cells

#638
20070219131
2007-09-20

COMPOSITIONS CAPABLE OF FACILITATING PENETRATION ACROSS A BIOLOGICAL BARRIER

#639
20070218118
2007-09-20

Methods and compositions for treating post-myocardial infarction damage

#640
20070207121
2007-09-06

Methods of Using and Compositions Comprising Selective Cytokine Inhibitory Drugs for Treatment and Management of Macular Degeneration

#641
20070202091
2007-08-30

Nutraceutical composition and method for promoting the rejuvenation of cells in warm-blooded animals including humans

#642
20070191597
2007-08-16

Sialic acid derivatives for protein derivatisation and conjugation

#643
20070191351
2007-08-16

Salts of potassium ATP channel openers and uses thereof

#644
20070179096
2007-08-02

Pharmaceutical Formulation

#645
20070179095
2007-08-02

Induction of tolerance by oral administration of factor VIII and treatment of hemophilia

#646
20070178159
2007-08-02

In-Situ Forming Porous Scaffold

#647
20070178148
2007-08-02

Preparations of growth hormone

#648
20070172517
2007-07-26

Compositions capable of facilitation penetration across a biological barrier

#649
20070166362
2007-07-19

Transdermal and transmucosal preparations

#650
20070161753
2007-07-12

Biodegradable multi-block polymeric composition capable of sol-gel transition and pharmaceutical composition comprising the same

#651
20070161551
2007-07-12

Methods and compositions for the treatment of lipodystrophy

#652
20070154992
2007-07-05

Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants

#653
20070154559
2007-07-05

Nanoparticle compositions of water-soluble drugs for oral administration and preparation methods thereof

#654
20070141132
2007-06-21

Human growth hormone patch formulations

#655
20070141022
2007-06-21

Polymeric delivery agents and delivery agent compounds

#656
20070134266
2007-06-14

Growth hormone-containing formulation and method of use

#657
20070123470
2007-05-31

Enhancement of growth hormone levels with a dipeptidyl peptidase IV inhibitor and a growth hormone secretagogue

#658
20070105770
2007-05-10

Transglutaminase mediated conjugation of peptides

#659
20070098736
2007-05-03

Injection vehicle for polymer-based formulations

#660
20070087958
2007-04-19

Compounds and compositions for delivering active agents

#661
20070082043
2007-04-12

Liposomal vaccine

#662
20070081963
2007-04-12

Skin conditions using human growth hormone

#663
20070078096
2007-04-05

Buffered drug formulations for transdermal electrotransport delivery

#664
20070077283
2007-04-05

METHOD OF ENHANCING TRANSMUCOSAL DELIVERY OF THERAPEUTIC COMPOUNDS

#665
20070077273
2007-04-05

Microfabricated nanopore device for sustained release of therapeutic agent

#666
20070066532
2007-03-22

Compositions and methods for treatment of muscle pain and muscle wasting

#667
20070066519
2007-03-22

Use of human growth hormone in multiple system atrophy

#668
20070065469
2007-03-22

Liquid formulations with high concentration of human growth hormone (high) comprising glycine

#669
20070065454
2007-03-22

Liposomal vaccine

#670
20070059374
2007-03-15

Method of drug formulation based on increasing the affinity of active agents for crystalline microparticle surfaces

#671
20070059373
2007-03-15

Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents

#672
20070037861
2007-02-15

Enhanced method of treatment of growth disorders

#673
20070036767
2007-02-15

Postpartum cells derived from umbilical cord tissue, and methods of making and using the same

#674
20070027083
2007-02-01

Human growth hormone aqueous formulation

#675
20070027079
2007-02-01

GHRP 2 strips

#676
20070021326
2007-01-25

Composition and its Therapeutic Use

#677
20070015689
2007-01-18

Complexation of metal ions with polypeptides

#678
20070014818
2007-01-18

Liquid formulations with high concentration of human growth hormone (HGH) comprising 1,2-propylene glycol

#679
20070014771
2007-01-18

Postpartum cells derived from umbilical cord tissue, and methods of making and using the same

#680
20070009583
2007-01-11

Dressing

#681
20070009494
2007-01-11

Postpartum cells derived from umbilical cord tissue, and methods of making and using the same

#682
20070004626
2007-01-04

Methods and compositions for treating degenerative bone disorders

#683
20060281675
2006-12-14

Somatogenic therapy using a 20kda placental variant of growth hormone

#684
20060275353
2006-12-07

Stable topical drug delivery compositions

#685
20060275252
2006-12-07

Conjugates formed from polymer derivatives having particular atom arrangements

#686
20060258575
2006-11-16

Sustained-release microparticle preparation of human growth hormone and process for producing thereof

#687
20060257479
2006-11-16

Long-acting molecules in sustained release formulations

#688
20060252682
2006-11-09

Liquid growth hormone formulation and process of preparation thereof

#689
20060247315
2006-11-02

Method of treating intestinal disorders with citrulline

#690
20060246110
2006-11-02

Sustained release pharmaceutical composition

#691
20060241054
2006-10-26

Growth hormone-releasing peptides in the treatment or prevention of atherosclerosis and hypercholesterolemia

#692
20060234376
2006-10-19

Repair and regeneration of ocular tissue using postpartum-derived cells

#693
20060233740
2006-10-19

Conjugates of an hGH moiety and a polymer

#694
20060233715
2006-10-19

Compositions for nasal administration of pharmaceuticals

#695
20060223740
2006-10-05

Absorption enhancers such as e.g. BHT, BHA or propyl gallate

#696
20060211982
2006-09-21

Intracutaneous injection

#697
20060210629
2006-09-21

Zinc-containing sustained-release composition, its preparation, and method for producing the same

#698
20060193918
2006-08-31

Solvent/polymer solutions as suspension vehicles

#699
20060189529
2006-08-24

Modified human growth horomone polypeptides and their uses

#700
20060189520
2006-08-24

Treatment of diabetes

#701
20060188983
2006-08-24

Postpartum-derived cells for use in treatment of disease of the heart and circulatory system

#702
20060177417
2006-08-10

Pharmaceutical formulations for sustained drug delivery

#703
20060172929
2006-08-03

Use of natriuretic peptides for the treatment of stature disorders related to the shox gene

#704
20060171920
2006-08-03

Reversible pegylated drugs

#705
20060166871
2006-07-27

Medical compositions containing ghrelin

#706
20060166859
2006-07-27

Compounds and compositions for delivering active agents

#707
20060165800
2006-07-27

SHORT DURATION DEPOT FORMULATIONS

#708
20060165733
2006-07-27

Liquid formulations with high concentration of hunan growth hormone (hgh) comprising phenol

#709
20060154367
2006-07-13

Cartilage and bone repair and regeneration using postpartum-derived cells

#710
20060154366
2006-07-13

Method of differentiating umbilical cord tissue into a chondrogenic phenotype

#711
20060153818
2006-07-13

Cartilage and bone repair and regeneration using postpartum-derived cells

#712
20060153817
2006-07-13

Cartilage and bone repair and regeneration using postpartum-derived cells

#713
20060153816
2006-07-13

Soft tissue repair and regeneration using postpartum-derived cells and cell products

#714
20060153798
2006-07-13

Methods and compositions for needleless delivery of macromolecules

#715
20060148680
2006-07-06

Glycoproteins produced in plants and methods of their use

#716
20060148084
2006-07-06

Effect of growth hormone and IGF-1 on neural stem cells

#717
20060141550
2006-06-29

Novel metabolic targets and markers

#718
20060140874
2006-06-29

Stable aerosol formulations of peptides and protein with non-cfc propellants

#719
20060135427
2006-06-22

Formulations of human growth hormone comprising a non-naturally encoded amino acid at position 35

#720
20060134736
2006-06-22

Human growth hormone conjugated with biocompatible polymer

#721
20060134130
2006-06-22

Oral drug delivery compositions and methods

#722
20060127469
2006-06-15

Methods of delivering stable topical drug compositions

#723
20060122102
2006-06-08

Methods and preparations for curing critically ill patients

#724
20060122097
2006-06-08

Uptake of macromolecules

#725
20060121007
2006-06-08

Combined regulation of neural cell production

#726
20060120973
2006-06-08

Pharmaceutical formulations for intranasal administration of protein comprising a chitosan or a derivative thereof

#727
20060105955
2006-05-18

Topical drug delivery using phosphatidylcholine

#728
20060100186
2006-05-11

Transdermal compositions and methods for treatment of fibromyalgia and chronic fatigue syndrome

#729
20060094662
2006-05-04

Pharmaceutical compositions for sustained drug delivery

#730
20060088595
2006-04-27

Dispersant for sustained release preparations

#731
20060085003
2006-04-20

Use of autogenous growth factors in bone tunnels during ligament reconstruction

#732
20060084129
2006-04-20

Methods of determining contributions to metabolic pathways

#733
20060074024
2006-04-06

Treatment of congestive heart failure

#734
20060074019
2006-04-06

Human growth hormone treatment methods

#735
20060069026
2006-03-30

Treatment of obesity

#736
20060063807
2006-03-23

Low molecular weight peptidomimetic growth hormone secretagogues

#737
20060062772
2006-03-23

Polypeptide delivery system

#738
20060039987
2006-02-23

Method and apparatus for producing dry particles

#739
20060035374
2006-02-16

Method and device for multiplying and differentiating cells in the presence of growth factors and of a biological matrix or of a supporting structure

#740
20060029635
2006-02-09

Growth hormone formulations

#741
20060029581
2006-02-09

Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells

#742
20060026719
2006-02-02

Methods of producing peptides/proteins in plants and peptides/proteins produced thereby

#743
20060024393
2006-02-02

Antimicrobial prevention and treatment of human immunodeficiency virus and other infectious diseases

#744
20060013879
2006-01-19

Gel composition and methods

#745
20060003009
2006-01-05

Slow release protein polymers

#746
20050281879
2005-12-22

Excipients in drug delivery vehicles

#747
20050272815
2005-12-08

Compounds and compositions for delivering active agents

#748
20050272657
2005-12-08

Human growth hormone aqueous formulation

#749
20050272654
2005-12-08

NF-kappaB activation inhibitors, and their pharmaceutical uses

#750
20050271728
2005-12-08

High molecular weight medicine-containing preparation in powder form for administration through mucosa

#751
20050255167
2005-11-17

Medicinal Agent for Preventing and Treating Endocrine System Disturbances

#752
20050255162
2005-11-17

Hydrophobic biomolecular structure

#753
20050255138
2005-11-17

Active agent transport systems

#754
20050239891
2005-10-27

Use of citrulline within the framework of intestinal insufficiency

#755
20050220762
2005-10-06

Modified human interferon polypeptides and their uses

#756
20050201938
2005-09-15

Method for selectively inhibiting ghrelin action

#757
20050197286
2005-09-08

Method for control of depression using c terminal growth hormone (gh) fragment

#758
20050186176
2005-08-25

Compounds and compositions for delivering active agents

#759
20050181971
2005-08-18

Treatment of type i diabetes mellitus

#760
20050181059
2005-08-18

Nanoparticulate therapeutic biologically active agents

#761
20050171006
2005-08-04

Treatment of congestive heart failure

#762
20050171003
2005-08-04

Use of a growth hormone or a growth hormone secretagogue for appetite-suppression or induction of satiety

#763
20050170404
2005-08-04

Human growth hormone modified at position 35

#764
20050169979
2005-08-04

Liposomal vaccine

#765
20050169966
2005-08-04

Growth promoting pharmaceutical implant

#766
20050163725
2005-07-28

Method for administration of growth hormone via pulmonary delivery

#767
20050153899
2005-07-14

Therapeutical conversion

#768
20050147581
2005-07-07

Macromolecular drug complexes having improved stability and therapeutic use of the same

#769
20050137159
2005-06-23

Methods compositions and articles of manufacture for modulating bone growth

#770
20050124541
2005-06-09

Treatment of congestive heart failure

#771
20050118206
2005-06-02

Surfactant-based gel as an injectable, sustained drug delivery vehicle

#772
20050101671
2005-05-12

Compounds and compositions for delivering active agents

#773
20050090427
2005-04-28

Delivery of drugs to the bloodstream in toothpaste

#774
20050080007
2005-04-14

Pharmaceutical compositions comprising unacylated ghrelin and therapeutical uses thereof

#775
20050079145
2005-04-14

Stabilized reverse micelle compositions and uses thereof

#776
20050075298
2005-04-07

Methods and composition for delivering nucleic acids and/or proteins to the intestinal mucosa

#777
20050058702
2005-03-17

Compositions capable of facilitating penetration across a biological barrier

#778
20050058631
2005-03-17

Postpartum cells derived from placental tissue, and methods of making and using the same

#779
20050058630
2005-03-17

Postpartum-derived cells for use in treatment of disease of the heart and circulatory system

#780
20050058629
2005-03-17

Soft tissue repair and regeneration using postpartum-derived cells

#781
20050054098
2005-03-10

Postpartum cells isolated from umbilical cord tissue, and methods of making and using the same

#782
20050043231
2005-02-24

Therapy for growth hormone induced insulin resistance in juveniles with growth disorders

#783
20050037491
2005-02-17

Treatment of retinitis pigmentosa with human umbilical cord cells

#784
20050032702
2005-02-10

Medicinal product and method for treatment of conditions affecting neural stem cells or progenitor cells

#785
20050032209
2005-02-10

Regeneration and repair of neural tissue using postpartum-derived cells

#786
20050031549
2005-02-10

Compositions and methods for enhanced mucosal delivery of growth hormone

#787
20050026863
2005-02-03

Delivery of therapeutic gene products by intestinal cell expression

#788
20050025806
2005-02-03

Sustained release pharmaceutical composition

#789
20050019865
2005-01-27

Cartilage and bone repair and regeneration using postpartum-derived cells

#790
20050009746
2005-01-13

Treatment of HIV-associated dysmorphia/dysmetabolic syndrome (HADDS) with or without lipodystrophy

#791
20050009744
2005-01-13

Treatment of congestive heart failure

#792
20050008633
2005-01-13

Chemical and physical modulators of bioavailability of inhaled compositions

#793
20050004023
2005-01-06

Prevention of hyperinsulinemia in subjects undergoing growth hormone (GH) treatment

#794
14293851
2019-08-20

Fragments of growth hormone binding protein